{"version":"1.0","type":"link","title":"Real-world efficacy and safety of disitamab vedotin monotherapy or in combination with PD-1 inhibitors in locally advanced or metastatic upper tract urothelial carcinoma: a multicenter retrospective study.","author_name":"He S 외","author_url":"https://prs-insight.online/author/He%20S","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/169093","thumbnail_width":1200,"thumbnail_height":630}